Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 399

1.

Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol.

Fix OK, Bass NM, De Marco T, Merriman RB.

Liver Transpl. 2007 Jun;13(6):875-85.

2.
3.
4.

Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension.

Kuo PC, Johnson LB, Plotkin JS, Howell CD, Bartlett ST, Rubin LJ.

Transplantation. 1997 Feb 27;63(4):604-6.

PMID:
9047158
5.

Progressive portopulmonary hypertension after liver transplantation treated with epoprostenol.

Rafanan AL, Maurer J, Mehta AC, Schilz R.

Chest. 2000 Nov;118(5):1497-500.

PMID:
11083710
6.

Liver transplantation in patients with severe portopulmonary hypertension treated with preoperative chronic intravenous epoprostenol.

Tan HP, Markowitz JS, Montgomery RA, Merritt WT, Klein AS, Thuluvath PJ, Poordad FF, Maley WR, Winters B, Akinci SB, Gaine SP.

Liver Transpl. 2001 Aug;7(8):745-9. Review.

7.

The impact of treatment of portopulmonary hypertension on survival following liver transplantation.

Ashfaq M, Chinnakotla S, Rogers L, Ausloos K, Saadeh S, Klintmalm GB, Ramsay M, Davis GL.

Am J Transplant. 2007 May;7(5):1258-64. Epub 2007 Feb 7.

8.

Successful liver transplantation following medical management of portopulmonary hypertension: a single-center series.

Sussman N, Kaza V, Barshes N, Stribling R, Goss J, O'Mahony C, Zhang E, Vierling J, Frost A.

Am J Transplant. 2006 Sep;6(9):2177-82. Epub 2006 Jun 22.

9.

Successful adult-to-adult living donor liver transplantation in a patient with moderate to severe portopulmonary hypertension.

Uchiyama H, Soejima Y, Taketomi A, Yoshizumi T, Harada N, Ijichi H, Yonemura Y, Maehara Y.

Liver Transpl. 2006 Mar;12(3):481-4.

10.

Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.

Kähler CM, Graziadei I, Wiedermann CJ, Kneussl MP, Vogel W.

Wien Klin Wochenschr. 2000 Jul 28;112(14):637-40.

PMID:
11008327
11.

Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension.

Plotkin JS, Kuo PC, Rubin LJ, Gaine S, Howell CD, Laurin J, Njoku MJ, Lim JW, Johnson LB.

Transplantation. 1998 Feb 27;65(4):457-9.

PMID:
9500616
12.

Hemodynamics and survival of patients with portopulmonary hypertension.

Kawut SM, Taichman DB, Ahya VN, Kaplan S, Archer-Chicko CL, Kimmel SE, Palevsky HI.

Liver Transpl. 2005 Sep;11(9):1107-11.

13.

Rapid normalization of portopulmonary hypertension after living donor liver transplantation.

Sugimachi K, Soejima Y, Morita K, Ueda S, Fukuhara T, Nagata S, Ikegami T, Taketomi A, Maehara Y.

Transplant Proc. 2009 Jun;41(5):1976-8. doi: 10.1016/j.transproceed.2009.02.095.

PMID:
19545772
14.

Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series.

McLaughlin VV, Genthner DE, Panella MM, Hess DM, Rich S.

Ann Intern Med. 1999 May 4;130(9):740-3.

PMID:
10357693
15.

Recurrent portopulmonary hypertension after liver transplantation: management with epoprostenol and resolution after retransplantation.

Kett DH, Acosta RC, Campos MA, Rodriguez MJ, Quartin AA, Schein RM.

Liver Transpl. 2001 Jul;7(7):645-8.

16.

Use of aerosolized inhaled epoprostenol in the treatment of portopulmonary hypertension.

Schroeder RA, Rafii AA, Plotkin JS, Johnson LB, Rustgi VK, Kuo PC.

Transplantation. 2000 Aug 15;70(3):548-50.

PMID:
10949204
17.

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Hervé P, Rainisio M, Simonneau G.

J Am Coll Cardiol. 2002 Aug 21;40(4):780-8.

18.

[Epoprostenol in the treatment of portopulmonary hypertension].

Culafić D, Culafić-Vojinović V, Jesić R.

Srp Arh Celok Lek. 2003 May-Jun;131(5-6):271-4. Review. Serbian.

PMID:
14692137
19.

Orthotopic liver transplantation in a patient with severe portopulmonary hypertension.

Mair P, Kaehler CH, Pomaroli A, Schwarz B, Vogel W, Margreiter R.

Acta Anaesthesiol Scand. 2001 Apr;45(4):513-8.

PMID:
11300394
20.

Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.

Cabrol S, Souza R, Jais X, Fadel E, Ali RH, Humbert M, Dartevelle P, Simonneau G, Sitbon O.

J Heart Lung Transplant. 2007 Apr;26(4):357-62.

PMID:
17403477

Supplemental Content

Support Center